Straumann Holding AG (OTCMKTS:SAUHY) Given Average Recommendation of “Hold” by Analysts

Shares of Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) have been given a consensus recommendation of “Hold” by the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, one has issued a buy rating and two have given a strong buy rating to the company.

Several research analysts recently commented on SAUHY shares. UBS Group raised shares of Straumann from a “sell” rating to a “neutral” rating in a research note on Tuesday, November 4th. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. Citigroup reissued a “sell” rating on shares of Straumann in a research note on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft upgraded Straumann from a “hold” rating to a “buy” rating in a report on Friday, October 31st. Finally, The Goldman Sachs Group downgraded shares of Straumann from a “strong-buy” rating to a “neutral” rating in a research note on Monday, October 13th.

Get Our Latest Report on SAUHY

Straumann Stock Down 0.2%

Shares of Straumann stock opened at $11.68 on Friday. The stock’s fifty day moving average is $11.82 and its two-hundred day moving average is $12.05. Straumann has a 52 week low of $10.30 and a 52 week high of $15.07.

About Straumann

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Further Reading

Analyst Recommendations for Straumann (OTCMKTS:SAUHY)

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.